Multiple Intrahepatic Inflammatory Myofibroblastic Tumor on 68Ga-FAPI and 18F-FDG PET/CT
Author:
Affiliation:
1. Shijiazhuang Huabei Pharmaceutical Hospital of North China Medical and Health Group, Shijiazhuang, Hebei, China.
Abstract
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference11 articles.
1. Inflammatory myofibroblastic tumor of the liver mimicking metastasis on 18F-FDG PET/CT;Clin Nucl Med,2021
2. Inflammatory myofibroblastic tumour: state of the art;Cancers (Basel),2022
3. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond;Eur J Nucl Med Mol Imaging,2022
4. Mesenteric inflammatory myofibroblastic tumor on 68Ga-FAPI PET/CT;Clin Nucl Med,2021
5. Reply: [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer;Eur J Nucl Med Mol Imaging,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Postoperative Spindle Cell Nodule Mimicking Metastatic Lesion With Persistently Increasing 68Ga-FAPI-04 Uptake After Receiving Personalized Antigen Peptide Tumor Vaccine;Clinical Nuclear Medicine;2024-07-22
2. Multiresponsive luminescent metal–organic framework for cooking oil adulteration detection and gallium(III) sensing;Food Chemistry;2024-07
3. Diagnostic Performances of PET/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review;International Journal of Molecular Sciences;2024-06-29
4. Intense 18F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18F-FDG PET/CT;Clinical Nuclear Medicine;2024-03-07
5. Comparison of 18F-FDG and 18F-FAPI PET/CT Findings of Signet-Ring Cell Carcinoma of the Stomach;Clinical Nuclear Medicine;2024-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3